Login / Signup

HIV prevention among men who have sex with men: tenofovir alafenamide combination preexposure prophylaxis versus placebo.

Paul N ZivichStephen R ColeJessie K EdwardsDavid V GliddenMoupali DasBonnie E Shook-SaYongwu ShaoMegha L MehrotraAdaora A AdimoraJoseph J Eron
Published in: The Journal of infectious diseases (2023)
There was a reduction in HIV infection with TAF/FTC versus placebo across 96-weeks of follow-up.
Keyphrases
  • men who have sex with men
  • hiv testing
  • hiv positive
  • antiretroviral therapy
  • double blind
  • phase iii
  • clinical trial
  • hiv infected
  • human immunodeficiency virus
  • placebo controlled
  • south africa
  • open label
  • gestational age